moclobemide has been researched along with Alogia in 2 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We randomised 90 acute stroke patients with aphasia to either 600 mg moclobemide or placebo daily for 6 months, within 3 weeks of the onset of stroke." | 9.11 | Long-term antidepressant treatment with moclobemide for aphasia in acute stroke patients: a randomised, double-blind, placebo-controlled study. ( Hellblom, A; Kahan, T; Laska, AC; Murray, V; von Arbin, M, 2005) |
| "We randomised 90 acute stroke patients with aphasia to either 600 mg moclobemide or placebo daily for 6 months, within 3 weeks of the onset of stroke." | 5.11 | Long-term antidepressant treatment with moclobemide for aphasia in acute stroke patients: a randomised, double-blind, placebo-controlled study. ( Hellblom, A; Kahan, T; Laska, AC; Murray, V; von Arbin, M, 2005) |
| "To compare standardized and functional aphasia tests in patients after acute stroke." | 2.73 | Clinical and prognostic properties of standardized and functional aphasia assessments. ( Bartfai, A; Hellblom, A; Kahan, T; Laska, AC; Murray, V, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laska, AC | 2 |
| von Arbin, M | 1 |
| Kahan, T | 2 |
| Hellblom, A | 2 |
| Murray, V | 2 |
| Bartfai, A | 1 |
2 trials available for moclobemide and Alogia
| Article | Year |
|---|---|
Long-term antidepressant treatment with moclobemide for aphasia in acute stroke patients: a randomised, double-blind, placebo-controlled study.
Topics: Aged; Aged, 80 and over; Aphasia; Double-Blind Method; Drug Administration Schedule; Female; Follow- | 2005 |
Clinical and prognostic properties of standardized and functional aphasia assessments.
Topics: Antidepressive Agents; Aphasia; Double-Blind Method; Follow-Up Studies; Humans; Moclobemide; Monoami | 2007 |